about
Mechanistic and regulatory aspects of intestinal iron absorptionIranian hereditary hemochromatosis patients: baseline characteristics, laboratory data and gene mutationsThe global prevalence of HFE and non-HFE hemochromatosis estimated from analysis of next-generation sequencing data.Increased iron stores correlate with worse disease outcomes in a mouse model of schistosomiasis infection.Pathophysiological consequences and benefits of HFE mutations: 20 years of research.Genome-wide association study identifies genetic loci associated with iron deficiency.The oral iron chelator deferiprone protects against systemic iron overload-induced retinal degeneration in hepcidin knockout mice.Hereditary hemochromatosis: a literature review and case report.Non-HFE hemochromatosisA genome-wide meta-analysis identifies 22 loci associated with eight hematological parameters in the HaemGen consortium.Polarized distribution of heme transporters in retinal pigment epithelium and their regulation in the iron-overload disease hemochromatosis.Loss of Hfe leads to progression of tumor phenotype in primary retinal pigment epithelial cells.Increased Retinal Expression of the Pro-Angiogenic Receptor GPR91 via BMP6 in a Mouse Model of Juvenile HemochromatosisDown-regulation of hepcidin in porphyria cutanea tardaIron-mediated retinal degeneration in haemojuvelin-knockout mice.Absence of iron-regulatory protein Hfe results in hyperproliferation of retinal pigment epithelium: role of cystine/glutamate exchangerExpression of hepcidin and other iron-related genes in type 3 hemochromatosis due to a novel mutation in transferrin receptor-2.Telomere length and elevated iron: the influence of phenotype and HFE genotypeA novel association between a SNP in CYBRD1 and serum ferritin levels in a cohort study of HFE hereditary haemochromatosis.The Regulation of Iron Absorption and Homeostasis.Iron metabolism: microbes, mouse, and man.Disorders associated with systemic or local iron overload: from pathophysiology to clinical practice.Essential but toxic: controlling the flux of iron in the body.Iron storage disease in Asia-Pacific populations: the importance of non-HFE mutations.Iron metabolism: from health to disease.Bone morphogenetic protein-binding endothelial regulator of liver sinusoidal endothelial cells induces iron overload in a fatty liver mouse model.Functional analysis and theoretical modeling of ferroportin reveals clustering of mutations according to phenotype.Iron loading increases ferroportin heterogeneous nuclear RNA and mRNA levels in murine J774 macrophages.Hereditary hemochromatosis due to resistance to hepcidin: high hepcidin concentrations in a family with C326S ferroportin mutation.Juvenile hemochromatosis: HAMP mutation and severe iron overload treated with phlebotomies and deferasirox.The dynamics of hepcidin-ferroportin internalization and consequences of a novel ferroportin disease mutation.An unexpected cause of liver cirrhosis and cardiomyopathy in a young man.TFR2 dimer binds 2xholoTFEvaluation of a bone morphogenetic protein 6 variant as a cause of iron loading.
P2860
Q26861531-D4A298DE-CA9A-4AF5-AB47-FE49D12F59B3Q30571110-8F354F23-FA44-4971-9D52-3B77EC01BF05Q31030085-81870754-5F36-459D-BD70-8B0C44CB1CADQ33541024-35107950-9A65-4873-A67D-C485766FDCEDQ33815961-3C7F447A-3227-4D5C-B1BF-EC4EBBAEC0DAQ33869815-57B99A5E-AD46-4894-A1DD-26221F612004Q33930882-62A5D974-7651-47BD-A1C9-13B0B2814617Q34027360-0217E89D-81C3-430F-B416-EFF898F8AB22Q34304892-2B2F0B38-554C-453A-845D-56C0939F0D6DQ35025798-F7520500-7EB3-4E01-A948-E8B515F51F0FQ35826659-223C1C28-3DB9-4D5A-A00A-2CEB17FF6AC3Q36530604-9A2ECC73-55DB-4AF1-89AB-CEDA916ACE35Q36776682-34ED7DE6-9435-41BE-9AF1-B81F7C15C1C2Q37002005-44D4B105-3853-4E7B-B7C0-F47A84089BE4Q37009398-3BEB2C66-DBA5-499F-83FD-70024FA2A1CBQ37035485-49CAD130-86D9-4708-A07C-66E1E752468BQ37082680-1D2765AD-2EE4-4270-9DED-91E998511088Q37201107-A35CD63A-5952-4ECC-AB6B-65024B6A6157Q37399509-052A0E10-F709-474C-AAE9-4E3A4C31D05EQ37543492-3571AD52-EC89-447C-B10B-0EBE32834D1AQ37624574-AA07601A-F873-4970-9959-8116B047D668Q37928941-6A9FD796-F427-4AAB-B89C-3784F9B1844AQ37972662-C3F4F9A2-4E1D-44C3-80C2-EB0A4E5F9029Q38098239-6EFEAFAA-7B37-4D32-86F9-003724BD9446Q38183337-90825D71-95F6-49CC-9D68-322C1CD7F102Q39641378-BD795BAC-12F2-4CB3-A2C1-C091C40B1F7EQ39784883-2E3F3E96-1AA9-4395-9F5D-914F0A5C0867Q39895736-24746D9A-EBDD-4F99-AF2C-52133F084688Q42561633-8E91EE45-E25A-41F7-BB55-4B77A17538AEQ47123552-EC1405C3-1AD5-4A5A-8B5C-E9726D4EA5D6Q48168878-428D3B93-34C8-42F9-9EC5-6477EB2DB587Q48188816-3E7EA21E-FBF6-44C0-B4A7-658B0C09D732Q50299621-56F43592-18C9-4956-865A-47E31B2CB15CQ52563107-A52E6799-00A2-45A4-AA75-9CD269018C8A
P2860
description
2007 nî lūn-bûn
@nan
2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Non-HFE haemochromatosis.
@ast
Non-HFE haemochromatosis.
@en
Non-HFE haemochromatosis.
@nl
type
label
Non-HFE haemochromatosis.
@ast
Non-HFE haemochromatosis.
@en
Non-HFE haemochromatosis.
@nl
prefLabel
Non-HFE haemochromatosis.
@ast
Non-HFE haemochromatosis.
@en
Non-HFE haemochromatosis.
@nl
P2860
P356
P1476
Non-HFE haemochromatosis.
@en
P2093
Daniel-F Wallace
V-Nathan Subramaniam
P2860
P304
P356
10.3748/WJG.V13.I35.4690
P407
P577
2007-09-01T00:00:00Z